Contact UsQuotation
Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

FX-909

😃Good
Catalog No. T73519Cas No. 2924573-90-8
Alias FX909, FX 909

FX-909 is a covalent peroxisome proliferator–activated receptor gamma (PPARγ) inverse agonist developed for advanced solid malignancies, including muscle-invasive bladder cancer, and functional profiling and NMR studies demonstrate that FX-909 exhibits enhanced corepressor-selective inverse agonism and superior stabilization of a transcriptionally repressive PPARγ ligand-binding domain conformation compared with T0070907.

FX-909

FX-909

😃Good
Purity: 99.53%
Catalog No. T73519Alias FX909, FX 909Cas No. 2924573-90-8
FX-909 is a covalent peroxisome proliferator–activated receptor gamma (PPARγ) inverse agonist developed for advanced solid malignancies, including muscle-invasive bladder cancer, and functional profiling and NMR studies demonstrate that FX-909 exhibits enhanced corepressor-selective inverse agonism and superior stabilization of a transcriptionally repressive PPARγ ligand-binding domain conformation compared with T0070907.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$1,520-In Stock
50 mg$1,980-In Stock
100 mg$2,500-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.53%
Contact us for more batch information

Resource Download

COA LCMS HNMR

Product Introduction

Bioactivity
Description
FX-909 is a covalent peroxisome proliferator–activated receptor gamma (PPARγ) inverse agonist developed for advanced solid malignancies, including muscle-invasive bladder cancer, and functional profiling and NMR studies demonstrate that FX-909 exhibits enhanced corepressor-selective inverse agonism and superior stabilization of a transcriptionally repressive PPARγ ligand-binding domain conformation compared with T0070907.
SynonymsFX909, FX 909
Chemical Properties
Molecular Weight360.33
FormulaC17H10F2N2O3S
Cas No.2924573-90-8
SmilesN#CC=1C=CC(=C(C1)C2=CC(=O)C=3C(F)=CC(F)=CC3N2)S(=O)(=O)C
ColorWhite
AppearanceSolid
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (222.02 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7752 mL13.8762 mL27.7523 mL138.7617 mL
5 mM0.5550 mL2.7752 mL5.5505 mL27.7523 mL
10 mM0.2775 mL1.3876 mL2.7752 mL13.8762 mL
20 mM0.1388 mL0.6938 mL1.3876 mL6.9381 mL
50 mM0.0555 mL0.2775 mL0.5550 mL2.7752 mL
100 mM0.0278 mL0.1388 mL0.2775 mL1.3876 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Stock solution preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (stock solution concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
The above example illustrates how to use "In Vivo Formulation Calculator" and does not represent a recommended formulation for any specific compound. Please select an appropriate dissolution method based on your experimental animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy FX-909 | purchase FX-909 | FX-909 cost | order FX-909 | FX-909 chemical structure | FX-909 formula | FX-909 molecular weight
TargetMol | Logo

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.